+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

ASF Research Grant

Angelman Syndrome Foundation

The Angelman Syndrome Foundation (ASF) is committed to funding groundbreaking scientific research that brings us closer to effective treatments and improved care for individuals with Angelman syndrome (AS). Our annual call for research proposals invites scientists and clinicians worldwide to submit innovative studies that align with our 2025 ASF Research Roadmap and priorities.

Apply for a Research Grant

ASF accepts research proposals on a continual basis, with annual submission deadlines for review on August 15th.

Funding Amount: Up to $100,000 per year

Grant Duration: One- or two-year grants

AI Based Application Success Predictor

1. Strong alignment with ASF research priorities (highest predictor)

This is the most important predictor.

ASF prioritizes projects that address key aspects of Angelman syndrome, including:

UBE3A biology and regulation
Disease mechanisms and pathophysiology
Brain and neuronal function
Biomarker development
Therapeutic development
Gene-targeted therapies
Clinical and translational research
Natural history and outcome measures

Projects that closely align with the Foundation's Research Roadmap are the most competitive.

2. Strong scientific merit and innovation (very high predictor)

ASF formally evaluates proposals for scientific merit during peer review.

Competitive applications generally include:

Novel hypotheses
Innovative therapeutic approaches
New disease models
Cutting-edge technologies
High-impact scientific questions

Projects that significantly advance understanding or treatment of Angelman syndrome are favored.

3. Clear potential to improve treatment and patient outcomes (very high predictor)

ASF's mission is to accelerate research that leads to meaningful improvements for individuals with Angelman syndrome.

Strong proposals typically demonstrate potential to:

Develop disease-modifying therapies
Improve neurological function
Enhance quality of life
Improve diagnosis or monitoring
Advance clinical trials
Accelerate translation to patient care

Projects with a realistic path toward therapeutic development receive strong consideration.

4. Feasible and rigorous research design

Feasibility is one of ASF's formal review criteria.

Competitive proposals include:

Clearly defined objectives
Robust methodology
Appropriate experimental design
Realistic timelines
Well-justified budgets
Achievable milestones

Reviewers assess whether the proposed work can be successfully completed within the one- or two-year funding period.

5. Translational relevance

ASF supports the full spectrum of research but places strong emphasis on moving discoveries toward therapies.

Competitive studies often involve:

Preclinical therapeutic testing
Biomarker validation
Gene therapy
Antisense oligonucleotides
Small-molecule therapeutics
Clinical trial readiness

Projects that bridge laboratory discoveries and clinical application are particularly attractive.

6. Strong investigator expertise and collaborative environment

Successful applicants generally demonstrate:

Expertise in neuroscience
Experience in genetics or rare diseases
Prior publications
Access to Angelman syndrome models or patient cohorts
Collaborative multidisciplinary teams

A strong institutional environment enhances confidence in successful project completion.

7. Potential to generate preliminary data for future funding

ASF grants frequently function as seed funding.

Competitive projects often:

Generate proof-of-concept data
Establish new therapeutic directions
Support future NIH or foundation applications
Build larger translational research programs

Projects with clear follow-on funding potential are especially valuable.

8. Focus on UBE3A biology and disease mechanisms

Recent ASF funding announcements highlight particular interest in:

Regulation of UBE3A expression
Cell-type-specific effects of UBE3A loss
Brain-region-specific disease mechanisms
Protein regulation and neuronal function
Molecular pathways underlying Angelman syndrome

Research addressing these priority areas aligns especially well with current Foundation interests.

9. Potential for broad impact on the Angelman syndrome field

Reviewers favor projects that can:

Advance the overall understanding of Angelman syndrome
Enable future therapeutic development
Create broadly useful research tools or biomarkers
Benefit the wider Angelman research community

Projects with broad scientific and clinical impact are highly competitive.

Specialties

Genetics & Genomics

Neurosciences

Eligibility Requirements

Researchers, clinicians, and institutions focused on advancing Angelman syndrome research

Sponsor Details

Sponsor Institute/Organizations: Angelman Syndrome Foundation

Sponsor Type: Corporate/Non-Profit

Address: 3015 E. New York Street, Suite A2 #285, Aurora, IL 60504

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity